Mammoth Biosciences
Sanjay Parate is a seasoned financial professional with extensive experience in financial planning and analysis, currently serving as the Financial Planning and Analysis Manager at Mammoth Biosciences since 2022. Prior to this role, Sanjay held similar positions at Cutera, Inc., where responsibilities included leading cross-functional teams, preparing budgets for executive review, and conducting variance analyses. Sanjay's background also includes significant contributions at Fluidigm Corporation and Genentech, with a focus on cost accounting and financial reporting. With an MBA from Texas State University, Sanjay has a proven track record of implementing financial processes, conducting detailed analyses, and fostering collaborations across various departments to optimize budgeting and financial performance.
This person is not in any teams
Mammoth Biosciences
3 followers
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to improve lives by reading and writing the code of life. Mammoth aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, Cas14, and CasΦ, Mammoth can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber.